Effectiveness of Acupuncture for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis

World Health Organization. Dementia Fact sheet May 2017. Available from: http://www.who.int/mediacentre/factsheets/fs362/en/ .

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016, 388(10053): 1545–1602

GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 385(9963): 117–171

Burns A, Iliffe S. Dementia. Bmj, 2009, 338(7691): b75

Sanabria-Castro A, Alvarado-Echeverria I, Monge-Bonilla C. Molecular Pathogenesis of Alzheimer’s Disease: An Update. Ann Neurosci, 2017, 24(1): 46–54

Bierer LM, Haroutunian V, Gabriel S, et al. Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits. J Neurochem, 1995, 64(2): 749–760

Croxson PL, Kyriazis DA, Baxter MG. Cholinergic modulation of a specific memory function of prefrontal cortex. Nat Neurosci, 2011, 14(12): 1510–1512

Pabst M, Braganza O, Dannenberg H, et al. Astrocyte Intermediaries of Septal Cholinergic Modulation in the Hippocampus. Neuron, 2016, 90(4): 853–865

Sucher NJ, Awobuluyi M, Choi YB, et al. NMDA receptors: from genes to channels. Trends Pharmacol Sci, 1996, 17(10): 348–355

Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med, 1994, 330(9): 613–622

Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev, 2006, (1): Cd005593

Lleo A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer’s disease. Annu Rev Med, 2006, 57(1): 513–533

McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev, 2006, (2): Cd003154

Rolinski M, Fox C, Maidment I, et al. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev, 2012, (3): Cd006504

Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol, 2007, 6(9): 782–792

Courtney C, Farrell D, Gray R, et al. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial. Lancet, 2004, 363(9427): 2105–2115

Gustavsson A, Brinck P, Bergvall N, et al. Predictors of costs of care in Alzheimer’s disease: a multinational sample of 1222 patients. Alzheimers Dement, 2011, 7(3): 318–327

Wang XR, Shi GX, Yang JW, et al. Acupuncture ameliorates cognitive impairment and hippocampus neuronal loss in experimental vascular dementia through Nrf2-mediated antioxidant response. Free Radic Biol Med, 2015, 89(9): 1077–1084

Forbes D, Thiessen EJ, Blake CM, et al. Exercise programs for people with dementia. Cochrane Database Syst Rev, 2015, (4): Cd006489

Wang Z, Nie B, Li D, et al. Effect of acupuncture in mild cognitive impairment and Alzheimer disease: a functional MRI study. PLoS One, 2012, 7(8): e42730

Lee MS, Shin BC, Ernst E. Acupuncture for Alzheimer’s disease: a systematic review. Int J Clin Pract, 2009, 63(6): 874–879

Zhou J, Peng W, Xu M, et al. The effectiveness and safety of acupuncture for patients with Alzheimer disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore), 2015, 94(22): e933

McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 1984, 34(7): 939–944

Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 1993, 43(11): 2412–2414

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th text version (DSM-IV): Washington, DC:APA., 2000. 943.

World Health Organization. The ICD-10 Classification of Metal and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 1992

Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975, 12(3): 189–198

Diaz-Venegas C, De La Vega S, Wong R. Transitions in activities of daily living in Mexico, 2001–2012. Salud Publica Mex, 2015, 57(Suppl 1): S54–S61

Ihl R, Ferris S, Robert P, et al. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer’s disease. Int J Geriatr Psychiatry, 2012, 27(1): 15–21

Rozzini L, Chilovi BV, Conti M, et al. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry, 2007, 22(12): 1217–1222

Tsuboi K, Harada T, Ishii T, et al. Evaluation of the usefulness of a simple touch-panel method for the screening of dementia. Hiroshima J Med Sci, 2009, 58(2-3): 49–53

Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj, 2011, 343: d5928

Higgins JPT GS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 The Cochrane Collaboration 2011. Available from: http://handbook-5-1.cochrane.org/ .

Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414): 557–560

Millea P, Reed BR. Acupuncture in the treatment of Alzheimer Disease complicated by agitation: a randomized controlled pilot study. Med Acup, 2004, 15(3): 19–23

Yan XZ, Li ZY, Hua QH, et al. The effect of Tousanshen acupuncture in the treatment of Alzheimer’s disease on plasma Tau protein. J Bengbu Med Coll (Chinese), 2014, 39: 302–306

Zhao LG, Ma L, Li YJ, et al. Clinical observation on Alzheimer’s disease treated by Acupuncture Dazhui (GV 14) and Baihui (GV 20). J Clin Acup Moxib (Chinese), 2007, 23(9): 42–43

Zhu H, Dong KL, Wu Y, et al. Effect of “Bushenhuoxue” Method on Cognitive Function Improvement of Alzheimer’s Disease Patients. Chin J Gerontol (Chinese), 2010, 30(11): 1493–1495

Jia YJ, Chen HY, Yu T, et al. Investigation on TCM Syndromes of Alzheimer’s Disease and Clinical Observation of treatment with “Fubenpaiyuan” Acupuncture. The third session of the academic conference of Chinese medicine, integrated traditional Chinese and Western Medicine and Geriatric medicine held by The World Federation of Chinese Medicine: Sichuan Province of China. 2010: 330–336

Gu W, Jin XX, Zhang YJ, et al. Clinical observation of Alzheimer’s disease treated with acupuncture. Chin Acup Moxib (Chinese), 2014, 34(12): 1156–1160

Wang KF, Zhang LJ, Chen XY. Clinical observation on 36 cases of Alzheimer’s disease treated by electro-acupuncture Dazhui (GV 14) and Baihui (GV 20). Chin J Trad Chin Med Pharm (Chinese), 2015, 30(3): 784–786

Liu ZB, Niu WM, Yang XH, et al. The clinical research of impact on cognitive function of patients with Alzheimer’s disease by using Xiu Sanzhen. Shan Xi J Traditional Chin Med (Chinese), 2008, 29(6): 711–712

Ke YM. Clinical Research on Acupuncture Treatment of Qi and Blood Deficiency type Senile Dementia. Heilongjiang Univ Chin Med (Chinese), 2014: 2–54

Lin H. Clinical study on treating Alzheimer’s Disease with “Yi Zhi Si Xiang” scalp acupuncture. Guangzhou Univ Chin Med (Chinese), 2016: 93–94

Liu J. Effect of Chinese Herbs Combined with Acupuncture on the Expression of Peripheral Blood TNF-α and IL-6 in Patients with Alzheimer’s Disease. Med Innov China (Chinese), 2015, 12(30): 93–95

Zhu YY. Observations on the Therapeutic Effect of Warm Needling on Senile Dementia. Shanghai J Acu-Mox (Chinese), 2014, 33(11): 996–997

Lin CR, Zhang JX, Guo JK, et al. Clinical observation on 18 cases of mild Alzheimer’s disease treated by “Tiaoshenyizhi” acupuncture. Chin J Gerontol (Chinese), 2014, 34(8): 2225–2226

Ou YQ, Li ZR, Mu YY, et al. Clinical Study on Acupuncture Treatment of Alzheimer’s Disease. Chin Acup Mox (Chinese), 1999, (7): 399–401

Li ZR, Mu YY, Ou YQ. Clinic control research of Alzheimer’s disease by the combination of acupuncture and Danggui Shaoyao San (DGSYS) of TCM. Chin J Clin Rehab (Chinese), 2002, 6(19): 2848–2849

O’Brien JT, Holmes C, Jones M, et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol, 2017, 31(2): 147–168

Ding X, Yu J, Yu T, et al. Acupuncture regulates the aging-related changes in gene profile expression of the hippocampus in senescence-accelerated mouse (SAMP10). Neurosci Lett, 2006, 399(1-2): 11–16

Hwang IK, Chung JY, Yoo DY, et al. Comparing the effects of acupuncture and electroacupuncture at Zusanli and Baihui on cell proliferation and neuroblast differentiation in the rat hippocampus. J Vet Med Sci, 2010, 72(3): 279–284

Hwang IK, Chung JY, Yoo DY, et al. Effects of electroacupuncture at Zusanli and Baihui on brain-derived neurotrophic factor and cyclic AMP response element-binding protein in the hippocampal dentate gyrus. J Vet Med Sci, 2010, 72(11): 1431–1436

Li G, Zhang X, Cheng H, et al. Acupuncture improves cognitive deficits and increases neuron density of the hippocampus in middle-aged SAMP8 mice. Acupunct Med, 2012, 30(4): 339–345

Liu Q, Zerbinatti CV, Zhang J, et al. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron, 2007, 56(1): 66–78

Liu ZB, Niu WM, Yang XB, et al. Effect of “Xiusanzhen” on expression of hippocampal Bcl-2 and Bax proteins in Alzheimer disease rats. Zhen Ci Yan Jiu (Chinese), 2011, 36(1): 7–11

Shibata M, Yamada S, Kumar SR, et al. Clearance of Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest, 2000, 106(12): 1489–1499

Wang Z, Liang P, Jia X, et al. The baseline and longitudinal changes of PCC connectivity in mild cognitive impairment: a combined structure and resting-state fMRI study. PLoS One, 2012, 7(5): e36838

Xue WG, Ge GL, Zhang Z, et al. Effect of electroacupuncture on the behavior and hippocampal ultrastructure in APP 695 V 717 I transgenic mice. Zhen Ci Yan Jiu (Chinese), 2009, 34(5): 309–314

Yang XH, Liu ZB, Niu WM, et al. Effect of “Xiusanzhen” on hippocampal muscarinic cholinergic receptor activity in Alzheimer disease rats. Zhen Ci Yan Jiu (Chinese), 2011, 36(2): 90–94

Zhang G, Yin H, Zhou YL, et al. Capturing amplitude changes of low-frequency fluctuations in functional magnetic resonance imaging signal: a pilot acupuncture study on NeiGuan (PC6). J Altern Complement Med, 2012, 18(4): 387–393

Zhang P, Guan SS, Jiang GH. Effects of electroa-cupuncture on expression of Abeta positive cells of the hippocampus and SOD activity in rats with streptozocin- Alzheimer’s disease. Zhongguo Zhen Jiu (Chinese), 2010, 30(12): 1007–1010